Xperi Corporation Announces Fourth Quarter and Full Year 2017 Results
"2017 was a year of change for our company and despite some challenges, we achieved a number of significant milestones which we believe will drive meaningful long-term shareholder value," said
| Financial Highlights | ||||||||||
|
($ in millions, except per share data) |
||||||||||
|
Q4 2017 |
Q4 2016 |
FY 2017 |
FY 2016 |
|||||||
| Revenue |
|
|
|
|
||||||
| GAAP Net Income (Loss) |
|
|
|
|
||||||
| Non-GAAP Net Income |
|
|
|
|
||||||
| GAAP EPS (LPS) |
|
|
|
|
||||||
| Non-GAAP EPS |
|
|
|
|
||||||
| Other Relevant Metrics |
Q4 2017 |
Q4 2016 |
FY 2017 |
FY 2016 |
||||||
| Purchase Accounting Impact |
|
|
|
|
||||||
| Operating Cash Flow |
|
|
|
|
||||||
| Cash, Cash Equivalents & S-T Investments |
|
|
|
|
||||||
| Total Debt |
|
|
|
|
||||||
| Debt Principal Paid |
|
|
|
|
||||||
1 GAAP EPS for Q4 2017 reflects the impact of tax adjustments, primarily from the Tax Cuts and Jobs Act, which increased the tax provision by approximately
2 Purchase Accounting Impact represents receipts from contracts with customers that are not recorded as revenue due to purchase accounting rules, but which would have been recorded as revenue if not for the acquisition of DTS. Internally, management includes the cash flow impact from these contracts when evaluating the Company's operating performance, when planning, forecasting and analyzing future periods, and when assessing the performance of its management team.
Stock Repurchase Program
During the fourth quarter of 2017, the Company repurchased approximately 269 thousand shares of common stock for an aggregate amount of
Dividends
On
Additionally, on
Debt Repricing
On
Financial Guidance
Consequent with the introduction of the new revenue accounting standard, ASC 606, the Company announced it would begin using billings as a key measure of business progress. As a result, the Company's outlook is now based on billings rather than revenue. For additional information regarding the Company's approach to guidance, please review the "ASC 606 Business Metrics and Guidance Approach" presentation given by the Company on
|
Q1 2018 |
GAAP Outlook |
Non-GAAP Outlook |
||||||
|
Billings |
|
|
||||||
|
FY 2018 |
GAAP Outlook |
Non-GAAP Outlook |
||||||
|
Billings |
|
|
||||||
|
Operating Expense |
|
|
||||||
|
Cash Tax Payments |
|
|
||||||
|
Fully Diluted Shares |
50.5 million | 52.5 million | ||||||
|
Operating Cash Flow |
|
|
||||||
Conference Call Information
The Company will hold its fourth quarter 2017, earnings conference call at
Safe Harbor Statement
This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected, particularly with respect to the Company's financial results and guidance and the Company's long-term strategy. Material factors that may cause results to differ from the statements made include the plans or operations relating to the businesses of the Company; market or industry conditions; changes in patent laws, regulation or enforcement, or other factors that might affect the Company's ability to protect or realize the value of its intellectual property; the expiration of license agreements and the cessation of related royalty income; the failure, inability or refusal of licensees to pay royalties; initiation, delays, setbacks or losses relating to the Company's intellectual property or intellectual property litigations, or invalidation or limitation of key patents; fluctuations in operating results due to the timing of new license agreements and royalties, or due to legal costs; the risk of a decline in demand for semiconductors and products utilizing our audio and imaging technologies; failure by the industry to use technologies covered by the Company's patents; the expiration of the Company's patents; the Company's ability to successfully complete and integrate acquisitions of businesses; the risk of loss of, or decreases in production orders from, customers of acquired businesses; financial and regulatory risks associated with the international nature of the Company's businesses; failure of the Company's products to achieve technological feasibility or profitability; failure to successfully commercialize the Company's products; changes in demand for the products of the Company's customers; limited opportunities to license technologies due to high concentration in applicable markets for such technologies; the impact of competing technologies on the demand for the Company's technologies; and other developments in the markets in which the Company operates, as well as management's response to any of the aforementioned factors. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release.
The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein and elsewhere, including the Risk Factors included in the Company's recent reports on Form 10-K and Form 10-Q and other documents of the Company on file with the
About
Recurring and IP Episodic Revenue
Recurring revenue is defined as revenue from a license agreement or other agreement that is scheduled to occur over at least one year of time. IP episodic revenue is Semiconductor and IP licensing business revenue payable within one year pursuant to a contract. IP episodic revenue includes non-recurring engineering fees, initial license fees, back payments resulting from audits, damages awarded by courts or other tribunals, and lump sum settlement payments.
Importantly, a source of IP episodic revenue may become a source of recurring revenue, when, for example, a company settles litigation with the Company by paying a settlement amount and entering into a license agreement that calls for an initial license fee and ongoing royalty payment over several years. In this scenario, the settlement amount would be episodic revenue, as would the initial license fee, and the ongoing royalties would be recurring revenue.
Non-GAAP Financial Measures
In addition to disclosing financial results calculated in accordance with
Set forth below are reconciliations of Company's reported GAAP net income (loss) to non-GAAP net income and GAAP to non-GAAP operating expenses guidance for 2018.
Xperi PR:
jordan.miller@xperi.com
or
geri.weinfeld@xperi.com
SOURCE:
XPER-E
|
|
||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
| (in thousands) | ||||||||
|
|
|
|||||||
| 2017 | 2016* | |||||||
| (unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 138,260 | $ | 65,626 | ||||
| Short-term investments | 62,432 | 47,379 | ||||||
| Accounts receivable, net | 17,010 | 15,863 | ||||||
| Unbilled contract receivables | 10,866 | 51,923 | ||||||
| Other current assets | 16,949 | 19,150 | ||||||
|
Total current assets |
245,517 | 199,941 | ||||||
| Property and equipment, net | 34,442 | 38,855 | ||||||
| Intangible assets, net | 431,789 | 541,879 | ||||||
|
|
385,574 | 382,963 | ||||||
| Other assets | 12,702 | 22,798 | ||||||
|
Total assets |
$ | 1,110,024 | $ | 1,186,436 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 4,233 | $ | 7,531 | ||||
| Accrued legal fees | 7,483 | 7,505 | ||||||
| Accrued liabilities | 47,969 | 29,086 | ||||||
| Current portion of long-term debt | 34,451 | 6,000 | ||||||
| Deferred revenue | 2,686 | 895 | ||||||
|
Total current liabilities |
96,822 | 51,017 | ||||||
| Long-term deferred tax liabilities | 15,085 | 32,565 | ||||||
| Long-term debt, net | 545,211 | 577,239 | ||||||
| Other long-term liabilities | 17,330 | 17,830 | ||||||
| Stockholders' equity: | ||||||||
| Common stock | 60 | 59 | ||||||
| Additional paid-in capital | 686,660 | 644,194 | ||||||
|
|
(319,397 | ) | (300,114 | ) | ||||
| Accumulated other comprehensive loss | (303 | ) | (148 | ) | ||||
| Retained earnings | 68,556 | 163,794 | ||||||
|
Total stockholders' equity |
435,576 | 507,785 | ||||||
|
Total liabilities and stockholders' equity |
$ | 1,110,024 | $ | 1,186,436 | ||||
| * Derived from audited financial statements | ||||||||
|
|
||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
| (in thousands, except per share amounts) | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||
|
|
|
|||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
|
Revenue: |
||||||||||||||||
|
Royalty and license fees |
$ | 126,647 | $ | 70,135 | $ | 373,732 | $ | 259,565 | ||||||||
|
Total revenue |
126,647 | 70,135 | 373,732 | 259,565 | ||||||||||||
| Operating expenses: | ||||||||||||||||
|
Cost of revenue |
1,938 | 313 | 6,308 | 551 | ||||||||||||
|
Research, development and other related costs |
27,684 | 15,740 | 105,849 | 44,738 | ||||||||||||
|
Selling, general and administrative |
36,446 | 37,315 | 144,649 | 72,065 | ||||||||||||
|
Amortization expense |
27,455 | 13,744 | 111,930 | 31,870 | ||||||||||||
|
Litigation expense |
9,129 | 8,531 | 36,496 | 20,953 | ||||||||||||
|
Total operating expenses |
102,652 | 75,643 | 405,232 | 170,177 | ||||||||||||
| Operating income (loss) | 23,995 | (5,508 | ) | (31,500 | ) | 89,388 | ||||||||||
| Interest expense | (7,416 | ) | (2,409 | ) | (28,292 | ) | (2,409 | ) | ||||||||
| Other income and expense, net | 444 | 1,264 | 1,449 | 3,736 | ||||||||||||
| Income (loss) before taxes | 17,023 | (6,653 | ) | (58,343 | ) | 90,715 | ||||||||||
| Provision for (benefit from) income taxes | 11,379 | 2,649 | (1,785 | ) | 34,626 | |||||||||||
| Net income (loss) | $ | 5,644 | $ | (9,302 | ) | $ | (56,558 | ) | $ | 56,089 | ||||||
| Basic and diluted net income (loss) per share: | ||||||||||||||||
|
Net income (loss) per share - basic |
$ | 0.11 | $ | (0.19 | ) | $ | (1.15 | ) | $ | 1.14 | ||||||
|
Net income (loss) per share - diluted |
$ | 0.11 | $ | (0.19 | ) | $ | (1.15 | ) | $ | 1.12 | ||||||
| Cash dividends declared per share | $ | 0.20 | $ | 0.20 | $ | 0.80 | $ | 0.80 | ||||||||
|
Weighted average number of shares used in per share calculations - basic |
49,217 | 48,603 | 49,251 | 49,187 | ||||||||||||
|
Weighted average number of shares used in per share calculations - diluted |
49,638 | 48,603 | 49,251 | 50,190 | ||||||||||||
|
|
||||||||||||||||
|
RECONCILIATION FROM GAAP NET INCOME (LOSS) TO NON-GAAP NET INCOME |
||||||||||||||||
| (in thousands, except per share amounts) | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||
|
|
|
|||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| GAAP net income (loss) | $ | 5,644 | $ | (9,302 | ) | $ | (56,558 | ) | $ | 56,089 | ||||||
| Adjustments to GAAP net income: | ||||||||||||||||
| Stock-based compensation expense: | ||||||||||||||||
| Research, development and other | 3,853 | 3,042 | 13,277 | 7,104 | ||||||||||||
| Selling, general and administrative | 5,648 | 7,019 | 20,185 | 13,997 | ||||||||||||
| Amortization of acquired intangibles | 27,455 | 13,744 | 111,930 | 31,870 | ||||||||||||
| Acquisition transaction costs | 9,339 | 1,837 | 11,100 | |||||||||||||
| Severance from DTS acquisition: | ||||||||||||||||
| Research, development and other | 510 | 1,379 | 734 | 1,379 | ||||||||||||
| Selling, general and administrative | 350 | 4,716 | 638 | 4,716 | ||||||||||||
| Post acquisition retention bonus to DTS employees: | ||||||||||||||||
| Research, development and other | 883 | 255 | 3,375 | 255 | ||||||||||||
| Selling, general and administrative | 2,785 | 986 | 11,128 | 986 | ||||||||||||
| Insurance settlement | - | - | - | (5,000 | ) | |||||||||||
| Tax adjustments for non-GAAP items | (7,051 | ) | (7,837 | ) | (34,785 | ) | (15,774 | ) | ||||||||
| Non-GAAP net income | $ | 40,077 | $ | 23,341 | $ | 71,761 | $ | 106,722 | ||||||||
| Non-GAAP net income per share - diluted | $ | 0.77 | $ | 0.45 | $ | 1.37 | $ | 2.06 | ||||||||
| Weighted average number of shares used in per share | ||||||||||||||||
| calculations excluding the effects of stock based compensation - diluted | 52,344 | 51,321 | 52,238 | 51,884 | ||||||||||||
|
|
||||||||||||||||
| EPISODIC AND RECURRING REVENUE | ||||||||||||||||
| (in thousands) | ||||||||||||||||
| (unaudited) | ||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||
|
|
|
|||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Revenue: | ||||||||||||||||
|
Episodic |
$ | 36,073 | $ | 10,100 | $ | 39,823 | $ | 15,786 | ||||||||
|
Recurring |
90,574 | 60,035 | 333,909 | 243,779 | ||||||||||||
|
Total revenue |
$ | 126,647 | $ | 70,135 | $ | 373,732 | $ | 259,565 | ||||||||
|
|
||||||||||||||
| RECONCILIATION FOR GUIDANCE ON | ||||||||||||||
| GAAP TO NON-GAAP OPERATING EXPENSE | ||||||||||||||
| (in millions) | ||||||||||||||
| (unaudited) | ||||||||||||||
| Twelve months ended | ||||||||||||||
|
|
||||||||||||||
| Low | High | |||||||||||||
|
Cost of revenue |
$ | 7 | $ | 10 | ||||||||||
| R&D expense | 115 | 121 | ||||||||||||
| SG&A expense | 133 | 137 | ||||||||||||
| Litigation expense | 30 | 35 | ||||||||||||
| Amortization | 109 | 109 | ||||||||||||
| GAAP expense | 394 | 412 | ||||||||||||
| Stock-based compensation - R&D | (15 | ) | (15 | ) | ||||||||||
| Stock-based compensation - SG&A | (22 | ) | (22 | ) | ||||||||||
| Acquisition & Related Expense - SG&A | (3 | ) | (3 | ) | ||||||||||
| Amortization | (109 | ) | (109 | ) | ||||||||||
| Total of non-GAAP adjustments | (149 | ) | (149 | ) | ||||||||||
| Non-GAAP expense | $ | 245 | $ | 263 | ||||||||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20180213006526/en/
Xperi PR:
jordan.miller@xperi.com
or
geri.weinfeld@xperi.com
Source:
News Provided by Acquire Media
